A Study to Assess the Safety and Pharmacokinetics of Single Ascending Subcutaneous and Intravenous Doses of DS-2325a in Healthy Subjects

Clinical trial NCT05388903 · COMPLETED

Trial details

NCT number: NCT05388903
Sponsor: Daiichi Sankyo
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Netherton Syndrome

Start date: 2022-06-20
Primary completion: 2023-01-26
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.